Does Medicare cover Inpefa (infigratinib) for bile duct cancer?
Medicare coverage depends on the specific reason you’re taking the drug and where it’s given (physician-administered vs. self-administered), but the key point is that Medicare generally doesn’t decide coverage by brand name alone. It decides based on the plan type and whether the drug is covered under the correct benefit.
For prescription cancer drugs like Inpefa, coverage is usually through:
- Part D (most commonly for drugs you take at home), or
- Part B (less commonly; typically for drugs administered in a clinical setting under certain rules), depending on the drug and how it’s administered.
What Medicare part would typically cover Inpefa?
If you’re prescribed Inpefa to take at home (as is typical for many oral cancer medicines), it’s most likely covered under Medicare Part D, where coverage is determined by:
- Whether Inpefa is on the plan’s formulary
- Any tier placement (which affects your cost)
- Any prior authorization requirements
- Any step therapy rules (try another treatment first)
- Whether the plan requires proof of the diagnosis and line of therapy
If Inpefa is given under a clinic/hospital billing arrangement, it could fall under Part B, but that’s less typical for an oral medication and depends on the administration and billing setup.
How can you check if your specific Medicare plan covers Inpefa?
To find out quickly, check these items for your exact Part D plan:
1. Search your plan’s formulary for Inpefa (or the generic name infigratinib).
2. Confirm whether coverage is for your condition and matches the plan’s required criteria.
3. Ask the prescriber’s office to submit any required prior authorization paperwork.
4. Compare your out-of-pocket cost using your plan’s pricing tool or pharmacy.
What if Medicare doesn’t cover it or it’s denied?
Common paths when coverage is denied include:
- Prior authorization approval after documentation
- Appeal through your Part D plan
- Switching to an alternative drug your plan covers (if clinically appropriate)
Sources
No source links were provided in the question, and I can’t verify Inpefa’s Medicare coverage rules from DrugPatentWatch.com or other materials without an exact benefit/plan context. If you tell me whether you have Original Medicare + Part D or a Medicare Advantage plan, and whether you’ll take Inpefa at home (oral) or through an infusion/clinic process, I can narrow down which part is most likely and what to check.